Susvimo, previously called Port Delivery System with ranibizumab, is the first wet AMD treatment in […]
Continue reading "FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)"
Late one night, Rylee Jebara woke to see dark objects lingering around his room. “I […]
Continue reading "New Australian-first gene therapy gives Rylee and Saman sight at night — and the chance at a new life"
A former science teacher who’s been blind for 16 years became able to see letters, […]
Continue reading "Scientists used a tiny brain implant to help a blind teacher see letters again"
Carlene Knight’s vision was so bad that she couldn’t even maneuver around the call center […]
Continue reading "A Gene-Editing Experiment Let These Patients With Vision Loss See Color Again"
World Retina Day is taking place on September 25th, 2021. This year, Retina International is highlighting […]
Continue reading "World Retina Day 2021: Theme Announcement"
X-linked retinitis pigmentosa (XLRP) is an inherited eye disease that causes gradual vision loss in […]
Continue reading "Retina Foundation Is Major Center for Next Phase of Gene Therapy for X-Linked Retinitis Pigmentosa: SKYLINE"
In PIONEER study, investigators outline their successes. Gene therapy is taking its first steps in […]
Continue reading "Partial visual function restored in patient with retinitis pigmentosa"
Clinical trials show subretinal agents are safe, well tolerated by patients. Preliminary results of 2 […]
Continue reading "Targeting gene therapy for achromatopsia"
Oxurion is currently recruiting patients for the Phase 2 clinical study of THR-687 in DME. […]
Continue reading "Biopharmaceutical firm taking next step in trials for intravitreal integrin antagonist"
A Phase I/II Dose Escalation Safety Study of Sub-Retinally Injected AAV expressing CNGB3, Administered to […]
Continue reading "Achromatopsia CNGB3 Gene Therapy Clinical Trial"